Budesonide Capsule, Coated Pellets
Product Images NDC 68382-720

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Budesonide (NDC 68382-720). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2f46f4cf 9f5a 43f4 871c 572414ad619b 01

FDA Label Image

2f46f4cf 9f5a 43f4 871c 572414ad619b 02

2f46f4cf 9f5a 43f4 871c 572414ad619b 02
This is a medicine description for Budesonide delayed-release capsules. The capsules contain 3mg of Budesonide and usual dosage is 3 capsules per day. The capsules should be stored at a controlled room temperature and dispensed in a light container, away from children's reach. The medicine is distributed by Zydus Pharmaceuticals (USA).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.